UnitedHealth Group Incorporated (NYSE:UNH) Receives $570.05 Consensus PT from Brokerages

UnitedHealth Group Incorporated (NYSE:UNH) has been assigned a consensus rating of “Moderate Buy” from the eighteen brokerages that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average 12-month target price among brokers that have covered the stock in the last year is $570.05.

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company dropped their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Truist Financial reissued a “buy” rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday, April 17th. TD Cowen dropped their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Morgan Stanley dropped their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Finally, Royal Bank of Canada dropped their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

Several institutional investors have recently added to or reduced their stakes in UNH. Robbins Farley acquired a new position in UnitedHealth Group in the third quarter valued at approximately $25,000. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. CGC Financial Services LLC raised its position in shares of UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $31,000. Finally, NewSquare Capital LLC raised its position in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.1 %

UNH stock opened at $483.70 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The company has a fifty day moving average price of $484.44 and a two-hundred day moving average price of $513.42. UnitedHealth Group has a one year low of $436.38 and a one year high of $554.70. The stock has a market cap of $445.04 billion, a price-to-earnings ratio of 29.57, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the previous year, the business posted $6.26 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.